by Michael Nevradakis, Ph.D., Childrens Health Defense:
Newly approved vaccines for respiratory syncytial virus have been linked to deaths and serious injuries and, most recently, to Guillain-Barré syndrome, but U.S. health officials continue to recommend them as “safe and effective.”
It’s been less than a year since the Centers for Disease Control and Prevention (CDC) recommended two new respiratory syncytial virus (RSV) vaccines — yet CDC data and the Vaccine Adverse Event Reporting System (VAERS) already show reports of 34 deaths, 302 serious adverse events and according to news reports this week, a safety signal for Guillain-Barré syndrome (GBS).